Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial

Mette Holm, I Dybedahl, Mette Holm, M Karimi, L Brandefors, H Garelius, M Grövdal, Inge Høgh Dufva, K Grønbæk, M Jansson, C Marcher, L Nilsson, A O Kittang, A Porwit, L Saft, L Möllgård, E Hellström-Lindberg

37 Citations (Scopus)
39 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences